Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
General Orthopaedics
Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis
JAMA. 2018;320(23):2448–2460. doi:10.1001/jama.2018.18472
Includes Author Interview
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis
This report has been verified by one or more authors of the original publication.
JAMA. 2018;320(23):2448–2460. doi:10.1001/jama.2018.18472
Arthroplasty
No improvement in reducing outliers in coronal axis alignment with patient-specific instrumentation
Knee Surg Sports Traumatol Arthrosc. 2018 Sep;26(9):2788-2796. doi: 10.1007/s00167-017-4741-1
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
No improvement in reducing outliers in coronal axis alignment with patient-specific instrumentation
Knee Surg Sports Traumatol Arthrosc. 2018 Sep;26(9):2788-2796. doi: 10.1007/s00167-017-4741-1
Osteoarthritis
Does intraoperative application of leukocyte-poor platelet-rich plasma during arthroscopy for knee degeneration affect postoperative pain, function and quality of life? A 12-month randomized controlled double-blind trial
Arch Orthop Trauma Surg. 2015 Jul;135(7):971-7.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Does intraoperative application of leukocyte-poor platelet-rich plasma during arthroscopy for knee degeneration affect postoperative pain, function and quality of life? A 12-month randomized controlled double-blind trial
This report has been verified by one or more authors of the original publication.
Arch Orthop Trauma Surg. 2015 Jul;135(7):971-7.
Tumour
Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole
Cancer. 2012 Mar 1;118(5):1192-201. doi: 10.1002/cncr.26313. Epub 2011 Oct 10
Includes Author Interview
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole
This report has been verified by one or more authors of the original publication.
Cancer. 2012 Mar 1;118(5):1192-201. doi: 10.1002/cncr.26313. Epub 2011 Oct 10